Open AccessIntravenous Acetaminophen Does Not Reduce Inpatient Opioid Prescription or Opioid-Related Adverse Events Among Patients Undergoing Spine Surgery
Author(s) -
Eva E. Mörwald,
Jashvant Poeran,
Nicole Zubizarreta,
Crispiana Cozowicz,
Madhu Mazumdar,
Stavros G. Memtsoudis
Publication year - 2018
Publication title -
anesthesia and analgesia/anesthesia and analgesia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.404
H-Index - 201
eISSN - 1526-7598
pISSN - 0003-2999
DOI - 10.1213/ane.0000000000003344
Subject(s) - medicine , perioperative , odds ratio , confidence interval , opioid , pregabalin , acetaminophen , anesthesia , gabapentin , medical prescription , adverse effect , analgesic , current procedural terminology , emergency medicine , surgery , pharmacology , alternative medicine , receptor , pathology
Having entered the US market relatively recently, the perioperative role of intravenous acetaminophen (ivAPAP) remains to be established for several surgeries. Using national data, we therefore assessed current utilization and whether it reduces inpatient opioid prescription and opioid-related side effects in a procedure with relatively high opioid utilization.